Benchmark Electronics earnings date
Want to see BHE full AI Analyst Report?
Benchmark Electronics (BHE) Q3 2026 Earnings Report
BHE Q3 2026 EPS Results
- Actual EPS
- $0.84
- Consensus EPS
- $0.79
- Beat/Miss
- Beat by +$0.05
- One Year Ago EPS
- $0.62
BHE Q3 2026 Revenue Results
- Actual Revenue
- $810.90M
- Expected Revenue
- $776.65M
- Beat/Miss
- Beat by +$34.25M
- YoY Revenue Growth
- +19.13%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/28/2026
- Time
- After Close
- Conference Call
- Wednesday, October 28, 2026
Benchmark Electronics's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was strongly positive. Benchmark reported record revenue and earnings, raised its outlook, delivered broad-based sector growth, improved margins and working capital, generated cash, and described healthy bookings and customer demand. The main challenges were supply chain constraints, a 2026 pause in A&D growth, lower inventory turns, and the delayed timing of next-generation HPC contributions, but these issues did not outweigh the company's positive operating and financial performance.
For the fourth quarter of 2026, Benchmark is guiding revenue to a range of $815 million to $855 million, representing 19% year-over-year growth at the midpoint, non-GAAP diluted earnings per share in the range of $0.85 to $0.91, non-GAAP gross margin of 10.5% to 10.7%, non-GAAP operating margin of 5.5% to 5.7%, approximately $7.8 million of stock-based compensation, $2.7 million to $3.2 million of nonoperating expenses, interest and other expenses of approximately $3.8 million, an effective tax rate in the range of 25% to 26%, and weighted average diluted shares outstanding of approximately 36.4 million; for the full year, it expects 16% annual growth, now exceeding $3 billion, and capital spending in the range of 2% to 2.5% of revenue. Semi-Cap revenue is expected to accelerate further year-over-year in the fourth quarter, followed by continued growth in 2027; Industrial is expected to deliver mid- to high single-digit growth for the full year; A&D is expected to return to growth in 2027; Medical remains on pace to deliver double-digit growth for the year; AC&C is expected to see a material sequential increase in the current quarter; and the current outlook assumes no contribution from next-generation HPC opportunities, which today appear more likely to begin contributing mid- to late 2027.
- Record Revenue and Earnings GrowthThird-quarter revenue was a record $811 million, up 19% year-over-year, while non-GAAP EPS was $0.84, up 35% year-over-year. Both exceeded the high end of prior guidance, and earnings growth significantly outpaced sales growth.
- Improved ProfitabilityThird-quarter non-GAAP gross margin was 10.5%, improving 40 basis points year-over-year. Non-GAAP operating margin was 5.5%, improving 70 basis points year-over-year and 30 basis points sequentially, reflecting favorable mix, higher revenue, and expense efficiencies.
- Raised Fourth-Quarter and Full-Year OutlookFourth-quarter revenue guidance is $815 million to $855 million, representing 19% year-over-year growth at the midpoint. Full-year 2026 revenue is expected to exceed $3 billion, with 16% annual growth. Fourth-quarter non-GAAP diluted EPS guidance is $0.85 to $0.91, with gross margin of 10.5% to 10.7% and operating margin of 5.5% to 5.7%.
- Strong Semi-Cap Performance and Long-Term Demand VisibilitySemi-Cap revenue grew 30% year-over-year and 8% sequentially, driven by strong end-market demand and new program wins. Management expects Semi-Cap revenue to accelerate further year-over-year in the fourth quarter and continue growing in 2027, while customer discussions indicate demand visibility extending into 2029 and 2030.
- Industrial Recovery and Improved OutlookIndustrial revenue increased 13% year-over-year and 7% sequentially, primarily due to new program awards from key existing customers. Management expects the pace to continue in Q4, positioning Industrial for mid- to high single-digit growth for the full year versus the initial expectation of relatively flat performance.
- Medical Growth and Significant New Program WinMedical revenue grew 9% year-over-year and 3% sequentially, primarily due to program ramps. The business remains on pace for double-digit growth in 2026, accelerating from high single-digit growth in 2025. Medical was one of the strongest bookings contributors in Q3 and included Benchmark's largest individual piece of new business awarded during the quarter from a new medical device customer.
- Outstanding AC&C GrowthAC&C revenue grew 50% year-over-year and 4% sequentially, driven by a major ramp that began earlier in the year. A manufacturing footprint expansion has already supported the ramp and is expected to enable a material sequential increase in AC&C revenue in the current quarter.
- Healthy Bookings and Broader Customer WinsBookings momentum remained healthy across the portfolio. Medical, Industrial, and Semi-Cap made the strongest contributions in Q3, following A&D's leading bookings performance in Q2. Management also said it has won share across the Semi-Cap portfolio since 2023, including programs from existing customers and new logos.
- Successful AI Infrastructure Capacity ExpansionA key AI infrastructure customer needed additional capacity on a compressed timeline. Benchmark expanded its manufacturing footprint, supported the customer's requirements, and successfully executed the ramp.
- Improved Cash Conversion and Cash GenerationThe cash conversion cycle improved to 54 days, 23 days better year-over-year and 5 days better sequentially. Q3 operating cash flow was $30 million and free cash flow was $14 million. Free cash flow was $113 million over the last 12 months.
- Strong Balance Sheet and Capital ReturnsBenchmark ended the quarter with $291 million of cash and $133 million net of debt. A $45 million revolver in Malaysia increased total available borrowing capacity to $576 million. The company returned $14 million to investors through dividends and share repurchases during Q3.
- Continued Investment in Capacity and CapabilitiesPT4 in Penang is ramping well, having come online in July 2026, and management said the facility has positioned Benchmark well for semiconductor growth. The planned Thailand building is expected to be completed in late 2027. Management also said it feels comfortable having capacity to take the business through 2027.
- A&D Bookings and Future Growth PositioningA&D bookings reached a company record in Q2 followed by another solid performance in Q3. Demand remains robust, particularly in defense and space, and recent bookings and program wins are positioning the sector to return to growth in 2027.
- Progress Toward Lower Structural Tax RateManagement said it is beginning to see progress on initiatives to structurally lower the tax rate. The anticipated fourth-quarter effective tax rate is 25% to 26%.
BHE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 0.88- | 0.71 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 0.790.84 | 0.62 | 35.48% (+0.22) | |
| Jul 29, 2026 | 2026 (Q2) | 0.690.75 | 0.55 | 36.36% (+0.20) | |
| Apr 29, 2026 | 2026 (Q1) | 0.560.58 | 0.52 | 11.54% (+0.06) | |
| Feb 03, 2026 | 2025 (Q4) | 0.640.71 | 0.61 | 16.39% (+0.10) | |
| Nov 04, 2025 | 2025 (Q3) | 0.580.62 | 0.57 | 8.77% (+0.05) | |
| Jul 30, 2025 | 2025 (Q2) | 0.540.55 | 0.57 | -3.51% (-0.02) | |
| Apr 29, 2025 | 2025 (Q1) | 0.500.52 | 0.55 | -5.45% (-0.03) | |
| Jan 29, 2025 | 2024 (Q4) | 0.560.61 | 0.58 | 5.17% (+0.03) | |
| Oct 30, 2024 | 2024 (Q3) | 0.540.57 | 0.57 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


